MeghanAnnHigmanMD

Oncology • Buffalo, NY

Assistant Professor, Pediatrics, University at Buffalo SUNY School of Medicine & Biomedical Sciences

Join to view full profile

Dr. Higman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Higman's full profile

Already have an account?

Office
219 Bryant St
Buffalo, NY 14222
Phone+1 716-878-7123

Fax+1 716-839-6740

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
UPMC Medical EducationResidency, Pediatrics, 1995 - 1998
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1995

Certifications & Licensure

NY State Medical License 2006 - 2025
MD State Medical License 1998 - 2006
PA State Medical License 1996 - 2006
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Buffalo Spree Magazine Castle Connolly, 2013-2014

Clinical Trials

Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed

Publications & Presentations

PubMed

23 citations
Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma.
Jennifer J.G. Welch, Cindy L. Schwartz, Meghan A. Higman, Lu Chen, Allen Buxton
Blood Advances. 2017-04-25
66 citations
Phase II Study of Pentostatin in Patients With Corticosteroid-Refractory Chronic Graft-Versus-Host Disease
David A. Jacobsohn, Allen R. Chen, Marianna Zahurak, Steven Piantadosi, Viki Anders
Journal of Clinical Oncology. 2007-09-20
197 citations
Chronic graft versus host disease.
Meghan A. Higman, Georgia B. Vogelsang
British Journal of Haematology. 2004-05-01

Abstracts/Posters

Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALL
Meghan A. Higman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Seven Roswell Park Physicians Recognized as ‘Exceptional Women in Medicine’March 21st, 2023
Castle Connolly Names 38 Roswell Park Physicians to ‘Top Doctors’ ListFebruary 2nd, 2023
Roswell Park Oncology Experts Named to Castle Connolly ‘Top Doctors’ ListAugust 4th, 2022